A Study of Degarelix in Taiwanese Patients With Prostate Cancer

Status:
Completed

Trial end date:
2012-10-01

Target enrollment:

Participant gender:

A phase III trial investigating the efficacy and safety of degarelix one-month depot in Taiwanese patients with prostate cancer.

Phase 3

Ferring Pharmaceuticals